Atrial fibrillation (AF) is a type of arrhythmia which is characterized by poor blood flow in the body due to an irregular and rapid heart rate. The geriatric population is generally more susceptible to this disease. Promising results in clinical trials for combination treatment for atrial fibrillation boosts the growth of the global atrial fibrillation market. C.R. Bard, Inc., Becton Dickinson & company, Baxter International, Inc., St. Jude Medical, Inc. Bristol-Myers Squibb Corporation, Johnson & Johnson, Sanofi, CardiofFocus, and Endoscopic Technologies are some key players in the market
Request for report sample of Atrial Fibrillation Market, here: http://www.marketresearchstore.com/report/world-atrial-fibrillation-market-opportunities-and-forecasts-68554
The atrial fibrillation market is segmented into treatment types and geography. On the basis of treatment types, the atrial fibrillation market is segmented into Pharmacological Treatment and Non-Pharmacological Treatment. The pharmacological treatment market is further segmented into anti-arrhythmic drugs and anti-coagulant drugs. The non-pharmacological treatment market is segmented into Catheter Ablation, Maze Surgery and Electric Cardioversion. Catheter ablation is segmented into radiofrequency based, cryoablation based, high intensity focused ultrasound based, microwave based and laser based catheter ablation procedures. Geographically, the atrial fibrillation market is segmented into North America, Europe, Asia-Pacific and LAMEA.
KEY BENEFITS
The report throws light on the dominant current trends. Based on the understanding of trends, revenues are forecast from 2013-2020.
Market intelligence for key developmental strategies adopted by top companies is explained with impact analysis.
Analysis of trends in various regions would help companies to plan their strategies depending on the region.
Drivers and opportunities are evaluated to highlight the top factors responsible for market growth.
Porter’s Five Forces analysis provides an insight into market dynamics and industry competition.
KEY MARKET SEGMENTS
MARKET BY TREATMENT TYPE
Pharmacological Treatment
Anti-arrhythmic drugs
Anti-coagulant drugs
Non-pharmacological Treatment
Catheter ablation
Radiofrequency based
Cryoablation based
High Intensity focused ultrasound based
Microwave based
Laser based
Maze surgery
Electric Cardioversion
MARKET BY GEOGRAPHY
North America
Europe
Asia-Pacific
LAMEA
